What is CYBERDYNE Inc. (CYBQF)?

CYBERDYNE Inc. (CYBQF) is a stock in the Healthcare sector, Medical - Devices industry. View full analysis on Stocks360.

What is the current price of CYBQF?

The current price of CYBQF is $1.39. Prices are updated in real time on Stocks360.

What is CYBQF's price-to-earnings (PE) ratio?

CYBQF's trailing twelve-month PE ratio is 153.85, based on current price and earnings per share data available on Stocks360.

What is CYBQF's market capitalization?

CYBQF's market capitalization is $185,202,235.00, placing it in the small-cap tier.

CYBERDYNE Inc. (CYBQF)

Stock analysis · OTC · Healthcare · Medical - Devices

$1.39

Market Cap

$185.20M

PE (TTM)

153.85

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.84

Day Range

$1.39 – $1.50

52-wk Range

$1.08 – $2.05

Avg Volume

N/A

Volume

6.00K

CYBERDYNE Inc. (CYBQF) is a publicly traded company in the Healthcare sector. Latest price: $1.39. Market cap $185.20M. Trailing PE 153.85. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-29 · $1.39 2026-10-28 · $1.39 (-0.14%)

Earnings

Most Recent

May 12, 2022

EPS $0.44 vs est. $-0.01

Beat by $0.45

Next Earnings

Nov 12, 2026

EPS estimate $0.00

Proprietary Signals

Signal snapshot temporarily unavailable.

About CYBERDYNE Inc.

CYBERDYNE Inc., founded in 2004 and headquartered in Tsukuba, Japan, is a multifaceted company involved in the entire product lifecycle—from research and development to production, sales, leasing, and maintenance—of advanced equipment and systems for both medical and defense applications within Japan. A cornerstone of their offerings is the Hybrid Assistive Limb (HAL) technology. This includes medical versions designed for lower limb and single joint rehabilitation, as well as non-medical variants providing assistance for lower limbs, single joints, and the lumbar region. They also produce various HAL peripherals. Beyond human augmentation, CYBERDYNE develops diverse robotic solutions, such as autonomous cleaning robots and transportation robots engineered for internal logistics across factories, offices, and other indoor environments. Another innovative product is Acoustic X, a high-speed LED array light source that facilitates real-time photoacoustic imaging. Their service portfolio features Cybernics Treatment, which leverages HAL to restore or enhance functional capabilities for individuals suffering from conditions like spinal cord injuries, strokes, and neuromuscular disease…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	153.85×
P/S (TTM)	6.89×
P/B	1.05×
PEG	0.00×
P/FCF (TTM)	-228.09×
EV / EBITDA	-33.28×
EV / Sales	3.64×
Earnings Yield	0.65%
Free Cash Flow Yield	-0.44%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$14.11B
Revenue (TTM)	$3.87B
Net Income (TTM)	$174.43M
Free Cash Flow (TTM)	-$3.84M
Net Debt	-$12.58B
Working Capital	$14.68B
Gross Margin	49.47%
Operating Margin	-26.83%
Net Margin	7.13%
Return on Equity	0.69%
Return on Invested Capital	-0.79%